Counselors in West Simsbury, CT Accepting Medicare
2 Counselors found. Showing 1 - 2
 Ms. Jacqueline Marie Alexander, MA, LPC, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 244 Farms Village Road, West Simsbury, CT 06092 Phone: 860-693-4599 Fax: 860-693-4452 |
Liza Rice Counselor Medicare: Not Enrolled in Medicare Practice Location: 6 Pasture Ln, West Simsbury, CT 06092 Phone: 860-836-4732 |
News Archive
What are the challenges facing palliative care during COVID-19?
The current COVID-19 outbreak affecting 180 countries and territories across six continents is taking its toll on healthcare systems globally. In particular, there is growing pressure on and concern for triage and palliative care departments. Now, researchers from the University of Toronto, Université Laval, Québec, and the University of Ottawa have published a new study titled, "Pandemic palliative care: beyond ventilators and saving lives," in the latest issue of the journal Canadian Medical Association Journal that looks to address the challenges in providing palliative care during a viral pandemic.
Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen
In a recent cutting-edge study, US researchers unveiled an anti-staphylococcal enterotoxin B monoclonal antibody that can be repurposed to target the cleavage site of the SARS-CoV-2 spike glycoprotein and, in turn, inhibit viral infection. Their findings are currently available on bioRxiv preprint server.
Cannabis use disorder more common in adults with pain
A new study published in the journal American Journal of Psychiatry reports that the use of cannabis for non-medical indications is much more common in adults who have pain than in others. This includes those who use marijuana very often or heavily enough to be considered to have a problem with dependence.
PREZISTA/ritonavir once-daily dosing for HIV-1 receives FDA approval for treatment in no DRV RAM adults
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 7 days ago